Caricamento...
Differential effects, on oncogenic pathway signalling, by derivatives of the HNF4 α inhibitor BI6015
BACKGROUND: Gastric cancer (GC) is a highly heterogeneous disease with few “targeted” therapeutic options. Previously, we demonstrated involvement of the transcription factor HNF4α in human GC tumours, and the developmental signal mediator, WNT5A, as a prognostic GC biomarker. One previously develop...
Salvato in:
| Pubblicato in: | Br J Cancer |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group UK
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6461897/ https://ncbi.nlm.nih.gov/pubmed/30792535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0374-5 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|